Lungpacer Medical has received FDA Premarket Approval for the AeroPace System

Dedicated to
Natural Breathing

Designed to help patients wean off
a ventilator and breathe on their own

Without a strong diaphragm it is impossible to breathe independently*

Artificial breathing support from a ventilator may weaken the diaphragm muscle more than 50% in less than one day* making it difficult to regain independent breathing.

Lungpacer is designed as a personal trainer for the diaphragm muscle*

Lungpacer’s AeroPace System is designed to stimulate the nerves that activate the diaphragm with repetitive exercises for 10-20 minutes twice per day to rebuild diaphragm strength and empower natural, independent breathing*.

Potential Benefits

Accelerated
Weaning

Fewer MV
Complications

Cost Effective

Reduced ICU Days

Seamless Integration

Outcomes from AeroPace Clinical Studies Showed

Using AeroPace compared to Standard of Care, more patients weaned.

0 %
Up to 35% reduced risk of remaining on MV at day 30
0 %
Up to 46% fewer reintubations and tracheostomies
3
Fewer days on MV
in the ICU
Lungpacer therapy provides an exciting potential solution to help mechanically ventilated patients return to natural breathing more quickly.
Dr. Joseph Shrager - Stanford University School of Medicine

Lungpacer Medical Research

10
Scientific Abstracts
& Presentations
5
Peer Reviewed
Publications
10 +
Patients
Studied

Learn more about results and trends from more than seven years of Lungpacer research.

Lungpacer AeroPace System

For patients unable to breathe on their own, the AeroPace therapy is designed to provide repetitive exercises, to rebuild diaphragm muscle strength critical to healthy breathing.

The AeroPace System is indicated to improve weaning success – increase weaning, reduce ventilator days, and reduce reintubation – in patients ages 18 years or older on mechanical ventilation at least 96 hours and who have not weaned.